Incidence and prevalence of lupus in Buenos Aires, Argentina: A 11-year health management organisation-based study

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Scolnik, M ^a   Marin, J ^a   Valeiras, S M ^a   Marchese, M F ^a   Talani, A S ^a   Avellaneda, N L ^a   Etchepare, A ^a   Etchepare, P ^a   Plou, M S ^a   Soriano, E R ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DNA ANTIBODY; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; RITUXIMAB; SM ANTIBODY;

ADULT; ARGENTINA; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; HEALTH CARE MANAGEMENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED CONNECTIVE TISSUE DISEASE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL; URBAN AREA;

EID: 84940435333     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000021     Document Type: Article

References (83)

1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 2006;15:308-18.
2. Pons-Estel GJ, Alarcón GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 2010;39:257-68.
3. INDEC. Direccion general de estadisticas y censos. Argentina: Censo Nacional de poblacion, hogares y vivienda, 2010. http://www. indec.gov.ar/ (last acceded 28 Jan 2014).
4. Dirección General de Estadística y Censos. Ministerio de Hacienda. Gobierno de la ciudad de Buenos Aires. Anuario Estadistico. 2009. http://www.estadistica.buenosaires.gob.ar/areas/hacienda/sis- estadistico/buscador.php?menu-id=18675 (last acceded 28 Jan 2014).
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
6. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 1990;17:1162-7.
7. Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985;14:43-6.
8. Nossent HC. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 2001;28:539-46.
9. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol 1998;27:98-105.
10. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 1985;24:147-54.
11. Alamanos Y, Voulgari PV, Siozos C, et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol 2003;30:731-5.
12. Ståhl-Hallengren C, Jönsen A, Nived O, et al. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
13. Alonso MD, Llorca J, Martinez-Vazquez F, et al. Systemic lupus erythematosus in northwestern Spain: A 20-year epidemiologic study. Medicine (Baltimore) 2011;90:350-8.
14. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993;32:110-15.
15. Johnson AE, Gordon C, Palmer RG, et al. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38:551-8.
16. Gourley IS, Patterson CC, Bell AL. The prevalence of systemic lupus erythematosus in Northern Ireland. Lupus 1997;6:399-403.
17. López P, Mozo L, Gutiérrez C, et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003;12:860-5.
18. Laustrup H, Voss A, Green A, et al. Occurrence of systemic lupus erythematosus in a Danish community: An 8-year prospective study. Scand J Rheumatol 2009;38:128-32.
19. Govoni M, Castellino G, Bosi S, et al. Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 2006;15:110-13.
20. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974; 134:1027-35.
21. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum 1985;28:80-6.
22. Michet CJ, McKenna CH, Elveback LR, et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
23. Uramoto KM, Michet CJ, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50.
24. McCarty DJ, Manzi S, Medsger TA, et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995;38:1260-70.
25. Naleway AL, Davis ME, Greenlee RT, et al. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005;14:862-6.
26. Balluz L, Philen R, Ortega L, et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol 2001;154:1029-36.
27. Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curaçao: An epidemiological investigation. Ann Rheum Dis 1992;51:1197-201.
28. Deligny C, Thomas L, Dubreuil F, et al. [Systemic lupus erythematosus in Martinique: An epidemiologic study]. Rev Med Interne 2002;23:21-9.
29. Senna ER, De Barros ALP, Silva EO, et al. Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach. J Rheumatol 2004;31:594-7.
30. Vilar MJP, Sato EI. Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 2002;11:528-32.
31. Gamboa R, Medina M, Acevedo E, et al. Prevalencia de enfermedades reumatológicas y discapacidad en una comunidad urbano-marginal: resultados del primer estudio COPCORD en el Perú. Rev Per Reuma 2009;15:40-6.
32. Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl 2011;86:3-8.
33. Reyes-Llerena GA, Guibert-Toledano M, Penedo-Coello A, et al. Community-based study to estimate prevalence and burden of illness of rheumatic diseases in Cuba: A COPCORD study. J Clin Rheumatol 2009;15:51-5.
34. Iseki K, Miyasato F, Oura T, et al. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994;23:547-54.
35. Kameda S. Epidemiologic study of systemic lupus erythematosus in Fukuoka population. Fukuoka Igaku Zasshi 1988;79:571-8.
36. Jakes RW, Bae S-C, Louthrenoo W, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 2012;64:159-68.
37. Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 2002;23:87-9.
38. Mok CC, To CH, Ho LY, et al. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol 2008;35:1978-82.
39. Nasonov E, Soloviev S, Davidson J, et al. The prevalence and incidence of Systemic Lupus Erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan). Lupus 2014;23:213-19.
40. Anstey NM, Bastian I, Dunckley H, et al. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust N Z J Med 1993;23:646-51.
41. Bossingham D. Systemic lupus erythematosus in the far north of Queensland. Lupus 2003;12:327-31.
42. Devins GM, Edworthy SM. Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus. Lupus 2000;9:534-41.
43. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982;25:601-11.
44. Halberg P, Alsbjørn B, Balslev JT, et al. Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome. Clin Rheumatol 1987;6:22-6.
45. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
46. Karlson EW, Daltroy LH, Lew RA, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995;38:267-73.
47. Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
48. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
49. Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum 1991;21:73-80.
50. Studenski S, Allen NB, Caldwell DS, et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987;30:1326-32.
51. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
52. Walsh SJ, Algert C, Gregorio DI, et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol 1995;22:1663-8.
53. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
54. González LA, Toloza SMA, McGwin G, et al. Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus 2013;22:1214-24.
55. Alarcón GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus 1999;8:197-209.
56. Alarcón GS, Rodríguez JL, Benavides G, et al. Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA cohort. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. Arthritis Care Res 1999;12:267-76.
57. Kaslow RA. High rate of death caused by systemic lupus erythematosus among U. S. residents of Asian descent. Arthritis Rheum 1982;25:414-18.
58. Thumboo J, Uramoto K, O'Fallon WM, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum 2001;45:494-500.
59. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore) 2004;83:1-17.
60. Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 2000;9:377-81.
61. Drenkard C, Villa AR, Garcia-Padilla C, et al. Remission of systematic lupus erythematosus. Medicine (Baltimore) 1996;75:88-98.
62. Fernandez RN, Rego JNA. LES: experiencia de 5 anos. Rev Bras Rheumatol Suppl 1992;32:41.
63. Harris EN, Williams E, Shah DJ, et al. Mortality of Jamaican patients with systemic lupus erythematosus. Br J Rheumatol 1989; 28:113-17.
64. Hernández-Cruz B, Tapia N, Villa-Romero AR, et al. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol 2001;19:395-401.
65. Johnson AE, Cavalcanti FS, Gordon C, et al. Crosssectional analysis of the differences between patients with systemic lupus erythematosus in England, Brazil and Sweden. Lupus 1994;3:501-6.
66. Massardo L, Jacobelli S. Occasional series: lupus around the world. The Chilean experience of systemic lupus erythematosus. Lupus 1996;5:175-7.
67. Massardo L, Martínez ME, Jacobelli S, et al. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994;24:1-11.
68. Molina JF, Drenkard C, Molina J, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) 1996;75:124-30.
69. Nossent JC. Course and prognostic value of systemic lupus erythematosus disease activity index in black caribbean patients. Semin Arthritis Rheum 1993;23:16-21.
70. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus 2000;9:601-6.
71. Vilá LM, Mayor AM, Valentín AH, et al. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999;8:279-86.
72. Pons-Estel GJ, Alarcón GS, Hachuel L, et al. Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort. Rheumatology (Oxford) 2012;51:1293-8.
73. Bellomio V, Spindler A, Lucero E, et al. Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus 2009;18:1019-25.
74. Seldin MF, Qi L, Scherbarth HR, et al. Amerindian ancestry in Argentina is associated with increased risk for systemic lupus erythematosus. Genes Immun 2008;9:389-93.
75. Garcia MA, Marcos JC, Marcos AI, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005;14:938-46.
76. Alarcón GS, McGwin G, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797-806.
77. Alarcón GS, McGwin G, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202.
78. Alarcón GS, McGwin G, Petri M, et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002;11:95-101.
79. Quintero-Del-Rió AI, Bacino D, Kelly J, et al. Familial systemic lupus erythematosus: A comparison of clinical manifestations and antibody presentation in three ethnic groups. Cell Mol Biol (Noisy-le-grand) 2001;47:1223-7.
80. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998;41:1173-80.
81. Soriano ER, Rosa J, Velozo E, et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: A 6-year health management organization-based study. Rheumatology (Oxford) 2011;50:729-34.
82. Rosa J, Garrot LF, Navarta DA, et al. Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires. J Clin Rheumatol 2013;19:303-7.
83. Rosa JE, Soriano ER, Narvaez-Ponce L, et al. Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires. J Clin Rheumatol 2011;17:59-63.